4//SEC Filing
Ciaffoni Joseph 4
Accession 0001062993-23-012809
CIK 0001267565other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:08 PM ET
Size
8.5 KB
Accession
0001062993-23-012809
Insider Transaction Report
Form 4
Ciaffoni Joseph
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-06-02$22.25/sh−1,000$22,251→ 275,000 total - Sale
Common Stock
2023-06-02$21.58/sh−30,272$653,173→ 276,000 total - Sale
Common Stock
2023-06-01$22.09/sh−31,272$690,758→ 306,272 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.81 to $22.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.09 to $22.085, inclusive.
- [F4]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.09 to $22.39, inclusive.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001443841
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 7:08 PM ET
- Size
- 8.5 KB